儿童患者万古霉素使用的真实世界研究

注册号:

Registration number:

ChiCTR1900022308 

最近更新日期:

Date of Last Refreshed on:

2019-04-04 12:06:42 

注册时间:

Date of Registration:

2019-04-04 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

儿童患者万古霉素使用的真实世界研究

Public title:

Clinical Use of Vancomycin in Pediatric Patients: A Real World Study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

儿童患者万古霉素使用的真实世界研究

Scientific title:

Clinical Use of Vancomycin in Pediatric Patients: A Real World Study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

吕萌 

研究负责人:

吕萌 

Applicant:

Lv Meng 

Study leader:

Lv Meng 

申请注册联系人电话:

Applicant telephone:

+86 15136114537

研究负责人电话:

Study leader's
telephone:

+86 15136114537

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lvmengyh@126.com

研究负责人电子邮件:

Study leader's E-mail:

lvmengyh@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河南省郑州市龙湖外环东路33号

研究负责人通讯地址:

河南省郑州市龙湖外环东路33号

Applicant address:

33 Longhu Outer Ring Road East, Zhengzhou, Henan

Study leader's address:

33 Longhu Outer Ring Road East, Zhengzhou, Henan

申请注册联系人邮政编码:

Applicant postcode:

450017

研究负责人邮政编码:

Study leader's postcode:

450017

申请人所在单位:

郑州大学附属儿童医院

Applicant's institution:

Children’s Hospital Affiliated to Zhengzhou

研究负责人所在单位:

郑州大学附属儿童医院

Affiliation of the Leader:

Children’s Hospital Affiliated to Zhengzhou

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2019-H-K07

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

郑州儿童医院伦理委员会

Name of the ethic committee:

Zhengzhou Children's Hospital Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2019-02-28 00:00:00

伦理委员会联系人:

周一博

Contact Name of the ethic committee:

Zhou Yibo

伦理委员会联系地址:

河南省郑州市龙湖外环东路33号

Contact Address of the ethic committee:

33 Longhu Outer Ring Road East, Zhengzhou, Henan

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

郑州大学附属儿童医院

Primary sponsor:

Children’s Hospital Affiliated to Zhengzhou

研究实施负责(组长)单位地址:

河南省郑州市龙湖外环东路33号

Primary sponsor's address:

33 Longhu Outer Ring Road East, Zhengzhou, Henan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南

市(区县):

郑州

Country:

China

Province:

Henan

City:

Zhengzhou

单位(医院):

郑州大学附属儿童医院

具体地址:

龙湖外环东路33号

Institution
hospital:

Children’s Hospital Affiliated to Zhengzhou

Address:

33 Longhu Outer Ring Road East

经费或物资来源:

2019年中国药学会科技开发中心项目(CMEI2019KPYJ(JZYY)00203)

Source(s) of funding:

2017 Annual Projects of Science and Technology Development Center of Chinese Pharmaceutical Association

研究疾病:

感染性疾病  

Target disease:

Infectious Diseases

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

上市后药物 

Study phase:

4

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

评价万古霉素在我院儿童患者使用的安全性和有效性。  

Objectives of Study:

To evaluate the safety and effectivity of vancomycin in pediatric patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 在外院有万古霉素使用治疗史;
2. 万古霉素血药浓度数值非稳态谷浓度者。

Exclusion criteria:

1. Patients with a therapeutic history of vancomycin;
2. Vancomycin TDM results were not steady trough concentration;

研究实施时间:

Study execute time:

From 2019-04-15 00:00:00 To 2019-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-04-15 00:00:00 To 2019-06-30 00:00:00

干预措施:

Interventions:

组别:

Case series

样本量:

200

Group:

Case series

Sample size:

干预措施:

万古霉素

干预措施代码:

Intervention:

Vancomycin

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河南 

市(区县):

郑州 

Country:

China

Province:

Henan

City:

Zhengzhou

单位(医院):

郑州大学附属儿童医院 

单位级别:

三甲 

Institution
hospital:

Children’s Hospital Affiliated to Zhengzhou

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

万古霉素谷浓度达标率

指标类型:

主要指标

Outcome:

the rate of vancomycin trough concentrations within the desired target range

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

用药过程中不良事件

指标类型:

主要指标

Outcome:

adverse events

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 18 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

N/A

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

中国临床试验注册中心

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Chinese clinical trial registry

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2019-04-04 12:06:14